Endovia Health Sciences, Inc. (EDVA) Free cash flow 2016–2024
Endovia Health Sciences, Inc. (EDVA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.3MFY2024 · since FY2016: -$26,311 → -$7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$7.3M | +28.4% |
| FY2023 | -$10.2M | +27.9% |
| FY2022 | -$14.1M | +3.8% |
| FY2021 | -$14.7M | +31.3% |
| FY2020 | -$21.4M | -701.5% |
| FY2019 | -$2.7M | -20071.3% |
| FY2018 | -$13,241 | +82.5% |
| FY2017 | -$75,872 | -188.4% |
| FY2016 | -$26,311 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDVA financial trends
EDVA RevenueEDVA Net incomeEDVA Net marginEDVA Gross profitEDVA Gross marginEDVA Operating incomeEDVA Operating marginEDVA Operating cash flowEDVA Capital expendituresEDVA Return on equityEDVA Stock buybacksEDVA Dividends paidEDVA Total assetsEDVA Total liabilitiesEDVA Shareholders’ equityEDVA overview →